2026 -now Chief Medical Officer @ Retension Pharmaceuticals
2025 -2026 SVP, Clinical Development @
2023 -2025 Chief Executive Officer @ Molecules to Medicine Advisory Group
2021 -2023 President of Research and Development @ Axcella Therapeutics
2019 -2020 CMO @
2017 -2019 Global Project Head @
2015 -2017 Global Program Head, Hemophilia @
2014 -2015 Vice President Of Business Development in Cardiovascular Disease and Heart Failure @
2008 -2013 Executive Director @
Alison Schecter Education
Mount Sinai School of Medicine of New York University
(Cardiology Research Fellowship)
1995-1996
Harvard Medical School 1993-1995
The Johns Hopkins University School of Medicine 1990-1993
Alison Schecter Summary
Alison Schecter, based in Cambridge, MA, US, is currently a Chief Medical Officer at Retension Pharmaceuticals. Alison Schecter brings experience from previous roles at Mineralys Therapeutics, Inc., Molecules to Medicine Advisory Group, Axcella Therapeutics and Selecta Biosciences. Alison Schecter holds a 1995 - 1996 Mount Sinai School of Medicine of New York University. Alison Schecter has 1 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.